Hrt Financial LP Pax Medica, Inc. Transaction History

Hrt Financial LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 13, 2023	SELL	$0.27 - $0.88 $4,106 - $13,383	-15,209 Reduced 58.54%	10,773 $3,000
Q2 2023 Aug 11, 2023	BUY	$0.76 - $2.08 $19,746 - $54,042	25,982 New	25,982 $20,000

Ticker PXMD
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,779,500
Market Cap $707K
Description
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.